Persistently low serum osteoprotegrin levels during the treatment of multiple myeloma patients predicts worse event-free survival

Saved in:
Bibliographic Details
Published inBiology of blood and marrow transplantation Vol. 10; p. 70
Main Authors Moreb, J.S., Zucali, J.R., Roberts, C.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.02.2004
Online AccessGet full text

Cover

More Information
ISSN:1083-8791
1523-6536
DOI:10.1016/j.bbmt.2003.12.077